Nural Orgun

540 total citations
14 papers, 449 citations indexed

About

Nural Orgun is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Nural Orgun has authored 14 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Nural Orgun's work include Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Nural Orgun is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Nural Orgun collaborates with scholars based in United States, Sweden and Switzerland. Nural Orgun's co-authors include Sing Sing Way, Yukang Lin, Oliver W. Press, John M. Pagel, Ajay K. Gopal, Damian J. Green, D. Scott Wilbur, Colin Havenar‐Daughton, Ganesh Kolumam and Kaja Murali‐Krishna and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Nural Orgun

14 papers receiving 443 citations

Peers

Countries citing papers authored by Nural Orgun

Since Specialization

Citations

This map shows the geographic impact of Nural Orgun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nural Orgun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nural Orgun more than expected).

Fields of papers citing papers by Nural Orgun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nural Orgun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nural Orgun. The network helps show where Nural Orgun may publish in the future.

Co-authorship network of co-authors of Nural Orgun

This figure shows the co-authorship network connecting the top 25 collaborators of Nural Orgun. A scholar is included among the top collaborators of Nural Orgun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nural Orgun. Nural Orgun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter 2014 ·Genes and Immunity ·Robert Lowe, Anna Genin, Nural Orgun, Randy Q. Cron	9
2	A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies 2013 ·Cancer Research ·Damian J. Green, Nural Orgun, Jon C. Jones, Mark D. Hylarides, John M. Pagel, Donald K. Hamlin, D. Scott Wilbur, Yukang Lin, Darrell R. Fisher, Aimee L. Kenoyer, Shani L. Frayo, Ajay K. Gopal, Johnnie J. Orozco, Theodore A. Gooley, Brent L. Wood, William Bensinger, Oliver W. Press	40
3	Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma 2011 ·Clinical Cancer Research ·Steven Park, (unknown), (unknown), Donald K. Hamlin, Yukang Lin, D. Scott Wilbur, Patrick S. Stayton, Nural Orgun, Mark D. Hylarides, Franz Buchegger, Aimee L. Kenoyer, (unknown), Ajay K. Gopal, Damian J. Green, John M. Pagel, Oliver W. Press	27
4	Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model 2011 ·Blood ·Damian J. Green, Nural Orgun, Mark D. Hylarides, John M. Pagel, Donald K. Hamlin, D. Scott Wilbur, Yukang Lin, (unknown), Shani L. Frayo, William Bensinger, Ajay K. Gopal, Johnnie J. Orozco, Theodore A. Gooley, Brent L. Wood, Oliver W. Press	1
5	Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model 2011 ·Blood ·John M. Pagel, Aimee L. Kenoyer, Tom Bäck, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, Steven I. Park, Shani L. Frayo, (unknown), Nural Orgun, Johnnie J. Orozco, (unknown), Yukang Lin, Ajay K. Gopal, Damian J. Green, Frederick R. Appelbaum, Oliver W. Press	46
6	Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease 2010 ·Blood ·Steven I. Park, (unknown), John M. Pagel, Don K. Hamlin, D. Scott Wilbur, Nural Orgun, Aimee L. Kenoyer, Shani L. Frayo, (unknown), Tom Bäck, Yukang Lin, Darrell R. Fisher, Ajay K. Gopal, Damian J. Green, Oliver W. Press	58
7	Conventional and Pretargeted Radioimmunotherapy with Bismuth-213 to Target and Treat CD20-Expressing Non-Hodgkin Lymphoma: A Preclinical Model for Consolidation Therapy to Eradicate Minimal Residual Disease. 2009 ·Blood ·Steven I. Park, (unknown), John M. Pagel, Donald K. Hamlin, Nural Orgun, Aimee L. Kenoyer, (unknown), (unknown), D. Scott Wilbur, Yukang Lin, Darrell R. Fisher, Ajay K. Gopal, Damian J. Green, Oliver W. Press	1
8	Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice 2009 ·Blood ·Scott E. James, Nural Orgun, Thomas F. Tedder, Mark J. Shlomchik, Michael C. Jensen, Yukang Lin, Philip D. Greenberg, Oliver W. Press	49
9	A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations 2009 ·Blood ·John M. Pagel, Nural Orgun, Donald K. Hamlin, D. Scott Wilbur, Theodore A. Gooley, Ajay K. Gopal, Steven I. Park, Damian J. Green, Yukang Lin, Oliver W. Press	42
10	Deviation from a Strong Th1-Dominated to a Modest Th17-Dominated CD4 T Cell Response in the Absence of IL-12p40 and Type I IFNs Sustains Protective CD8 T Cells 2008 ·The Journal of Immunology ·Nural Orgun, (unknown), Christopher B. Wilson, Sing Sing Way	42
11	Recombinant Listeria monocytogenes expressing an immunodominant peptide fails to protect after intravaginal challenge with herpes simplex virus-2 2008 ·Archives of Virology ·William J. Muller, Nural Orgun, Lichun Dong, David M. Koelle, Meei‐Li Huang, Sing Sing Way	5
12	A critical role for phospholipase C in protective immunity conferred by listeriolysin O-deficient Listeria monocytogenes 2007 ·Microbial Pathogenesis ·Nural Orgun, Sing Sing Way	10
13	Cutting Edge: Recombinant Listeria monocytogenes Expressing a Single Immune-Dominant Peptide Confers Protective Immunity to Herpes Simplex Virus-1 Infection 2007 ·The Journal of Immunology ·Mark T. Orr, Nural Orgun, Christopher Wilson, Sing Sing Way	48
14	IL-12 and Type-I IFN Synergize for IFN-γ Production by CD4 T Cells, Whereas Neither Are Required for IFN-γ Production by CD8 T Cells after Listeria monocytogenes Infection 2007 ·The Journal of Immunology ·Sing Sing Way, Colin Havenar‐Daughton, Ganesh Kolumam, Nural Orgun, Kaja Murali‐Krishna	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact